Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Flow and Blood Pressure Investigation in Down Syndrome or Trisomy 21: FBI21

NCT05528549 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT05528549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05528549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Flow and Blood Pressure Investigation in Down Syndrome or Trisomy 21: FBI21
Lead sponsor
University of Illinois at Chicago
Phase
Phase 3
Overall status
Completed
Start date
September 1, 2022
Completion date
April 26, 2023
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome